These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 12796751

  • 1. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
    Steinhubl S, Berger P.
    Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [Abstract] [Full Text] [Related]

  • 3. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
    Eshtehardi P, Windecker S, Cook S, Billinger M, Togni M, Garachemani A, Meier B, Hess OM, Wenaweser P.
    Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
    [Abstract] [Full Text] [Related]

  • 4. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.
    Am J Cardiol; 2006 Jan 01; 97(1):38-43. PubMed ID: 16377281
    [Abstract] [Full Text] [Related]

  • 5. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.
    Pharmacotherapy; 2007 May 01; 27(5):691-6. PubMed ID: 17461704
    [Abstract] [Full Text] [Related]

  • 6. Clopidogrel in interventional cardiology: questions answered and questions remaining.
    Nikhil JY, Radhakrishnan S, Paradiso-Hardy FL, Cohen EA.
    Can J Cardiol; 2002 Jul 01; 18(7):739-48. PubMed ID: 12167961
    [Abstract] [Full Text] [Related]

  • 7. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA.
    J Am Coll Cardiol; 2007 Feb 13; 49(6):657-66. PubMed ID: 17291930
    [Abstract] [Full Text] [Related]

  • 8. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A, Amit G, Cafri C, Gilutz H, Ilia R, Zahger D.
    Int J Cardiol; 2005 Sep 01; 103(3):293-7. PubMed ID: 16098392
    [Abstract] [Full Text] [Related]

  • 9. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
    Savonitto S, Ambrosini V, Marzocchi A, Tolaro S, Petronio AS, Galassi AR, Bongo AS, Gaglione A, Bolognese L, IDEA Survey Investigators, Italian Society of Invasive Cardiology.
    Ital Heart J; 2005 Feb 01; 6(2):106-18. PubMed ID: 15819503
    [Abstract] [Full Text] [Related]

  • 10. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.
    Thromb Res; 2009 May 01; 124(1):46-51. PubMed ID: 19041120
    [Abstract] [Full Text] [Related]

  • 11. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G, Gilard M, Le Feuvre C, Zaman AG.
    Nat Clin Pract Cardiovasc Med; 2006 Dec 01; 3(12):673-80. PubMed ID: 17122800
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA.
    Am J Manag Care; 2009 Mar 01; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [Abstract] [Full Text] [Related]

  • 13. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT, Regal RE, Dorsch MP.
    Ann Pharmacother; 2008 Apr 01; 42(4):550-7. PubMed ID: 18319394
    [Abstract] [Full Text] [Related]

  • 14. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Rajagopal V, Bhatt DL.
    Semin Thromb Hemost; 2004 Dec 01; 30(6):649-55. PubMed ID: 15630671
    [Abstract] [Full Text] [Related]

  • 15. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial.
    Circulation; 2004 Sep 07; 110(10):1202-8. PubMed ID: 15313956
    [Abstract] [Full Text] [Related]

  • 16. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S, Hoffmeister HM, Bode C.
    Herz; 2008 Jun 07; 33(4):244-53. PubMed ID: 18581073
    [Abstract] [Full Text] [Related]

  • 17. Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment.
    Valencia J, Mainar V, Bordes P, Pineda J, Gómez S, Sogorb F.
    J Interv Cardiol; 2008 Jun 07; 21(3):218-24. PubMed ID: 18422520
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E.
    Am J Cardiol; 2009 Nov 15; 104(10):1357-61. PubMed ID: 19892050
    [Abstract] [Full Text] [Related]

  • 19. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA.
    Rev Cardiovasc Med; 2006 Nov 15; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
    Karjalainen PP, Porela P, Ylitalo A, Vikman S, Nyman K, Vaittinen MA, Airaksinen TJ, Niemelä M, Vahlberg T, Airaksinen KE.
    Eur Heart J; 2007 Mar 15; 28(6):726-32. PubMed ID: 17267456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.